These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Long-term results of treatment of obesity]. Wechsler JG; Ditschuneit H Med Klin; 1980 Jul; 75(15):544-50. PubMed ID: 7001202 [No Abstract] [Full Text] [Related]
3. Clinical management of the obese adult. Bray GA Postgrad Med; 1972 May; 51(5):125-30. PubMed ID: 5063486 [No Abstract] [Full Text] [Related]
4. Evaluation of three anorexiants. Clortermine hydrochloride (voranil), fenfluramine hydrochloride (pondimin), and mazindol (sanorex). Dykes MH JAMA; 1974 Oct; 230(2):270-2. PubMed ID: 4606535 [No Abstract] [Full Text] [Related]
5. Response to starvation before and after a jejuno-ileal bypass operation for morbid obesity. Al Shamma GA; Fell GS; Joffe SN Scott Med J; 1979 Jul; 24(3):206-10. PubMed ID: 493949 [TBL] [Abstract][Full Text] [Related]
6. The management of obesity. Court JM Drugs; 1972; 4(5):411-8. PubMed ID: 4568066 [No Abstract] [Full Text] [Related]
7. The use of fenfluramine in patients undergoing therapeutic starvation. Wales JK Postgrad Med J; 1975; 51 Suppl 1():177. PubMed ID: 1219676 [No Abstract] [Full Text] [Related]
8. The treatment of obesity. Med Lett Drugs Ther; 1971 Jul; 13(15):61-2. PubMed ID: 5558450 [No Abstract] [Full Text] [Related]
10. The management of obesity. Danowski TS Hosp Pract; 1976 Apr; 11(4):39-46. PubMed ID: 1026627 [No Abstract] [Full Text] [Related]
11. [Experience with the appetite depressant, fenfluramine hydrochloride, in adiposity]. Liebermeister H; Probst G; Jahnke K Med Klin; 1969; 64(26):1201-7. PubMed ID: 5807324 [No Abstract] [Full Text] [Related]
12. The effect of a low-calorie diet with and without fenfluramine, and fenfluramine alone on the glucose tolerance and insulin secretion of overweight non-diabetics. Dykes JR Postgrad Med J; 1973 May; 49(571):314-7. PubMed ID: 4804455 [TBL] [Abstract][Full Text] [Related]
13. [The clinical evaluation of teronac (Mazindol) in the treatment of children with obesity. Part I. Effect of the drug on somatic patterns and exercise capacity (author's transl)]. Gołebiowska M; Chlebna-Sokoł D; Mastalska A; Zwaigzne-Raczyńska J Przegl Lek; 1981; 38(2):311-4. PubMed ID: 7017826 [No Abstract] [Full Text] [Related]
15. [Results of an excessive appetite]. de Boer HH Ned Tijdschr Geneeskd; 1978 Nov; 122(47):1825-6. PubMed ID: 714191 [No Abstract] [Full Text] [Related]
16. A comparative trial of different regimens of fenfluramine and phentermine in obesity. Steel JM; Munro JF; Duncan LJ Practitioner; 1973 Aug; 211(262):232-6. PubMed ID: 4580610 [No Abstract] [Full Text] [Related]
17. AN 448 Sandoz (Mazindol) in the treatment of obesity. Wallace AG Med J Aust; 1976 Mar; 1(11):343-5. PubMed ID: 775265 [TBL] [Abstract][Full Text] [Related]
18. Editorial: Psychoneurosis and obesity--the hen and egg dilemma. Vaisrub S JAMA; 1974 Oct; 230(4):591. PubMed ID: 4479108 [No Abstract] [Full Text] [Related]
19. Intestinal by-pass in the treatment of morbid obesity. A report of 120 successive cases without mortality. Espinoza FT; Stephenson RH Am J Gastroenterol; 1978 Mar; 69(3 Pt 1):307-10. PubMed ID: 665649 [No Abstract] [Full Text] [Related]
20. The control of food intake: effects of dieting and intestinal bypass. Bray GA; Dahms WT; Atkinson RL; Mena I; Taylor I; Rodin J; Schwartz A; Frame C Surg Clin North Am; 1979 Dec; 59(6):1043-54. PubMed ID: 531739 [No Abstract] [Full Text] [Related] [Next] [New Search]